AS

Alpana Shahi

Active Director Director DIN 07111091
DIN 07111091 First appointment Mar 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Alpana Shahi

Data last updated:

Alpana Shahi is a Director at Bio Nova Pharmaceuticals Pvt Ltd (since 2015). The company operates in Pharma. Bio Nova Pharmaceuticals Pvt Ltd reported revenue of ₹2.28 Cr (FY 2025).

DIN 07111091
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 2015
Oldest Company Age 47 yrs
Largest company Bio Nova Pharmaceuticals Pvt Ltd · ₹2.28 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bio Nova Pharmaceuticals Pvt Ltd U74899DL1979PTC009956
Director30 Mar 20151979₹2.28 Cr (FY 2025)Active

Board colleagues of Alpana Shahi

NameDINCompanyDesignation
Girish Shahi00926966Bio Nova Pharmaceuticals Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Bio Nova Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Alpana Shahi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alpana Shahi

Alpana Shahi currently holds 1 directorship: Bio Nova Pharmaceuticals Pvt Ltd (Director, since 30 Mar 2015, revenue ₹2.28 Cr (FY 2025)).

Alpana Shahi was first appointed on 30 Mar 2015 as Director at Bio Nova Pharmaceuticals Pvt Ltd.

The current boards of Alpana Shahi's companies include Girish Shahi (Bio Nova Pharmaceuticals Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available